Engineering Spleen-Targeting Bacterial Nanoplatform to Reprogram Immune Cells and Prevent Cancer Recurrence

Targeting the spleen with engineered mycobacterial nanocomplexes turns tumor-supporting cells into active cancer fighters through trained immunity.